Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors
Rani K. Powers(University of Colorado Anschutz Medical Campus), Joaquı́n M. Espinosa(University of Colorado Anschutz Medical Campus)
Cited by 143
Related Papers
Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program
|Genes & Development|2006|267
Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity
|Genome Research|2017|172
FAM193A is a positive regulator of p53 activity
|Cell Reports|2023|7
Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors
|bioRxiv (Cold Spring Harbor Laboratory)|2018|5
The COVIDome Explorer Researcher Portal
|medRxiv|2021|3